Sang‐Goo Shin

Jae Sung Lee, Jun Soo Kwon, Euitae Kim, 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Effect of the UGT2B15 Genotype on the Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Intravenous Lorazepam in Healthy Volunteers

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2005, Clinical pharmacology and therapeutics.

A variant 2677A allele of the MDR1 gene affects fexofenadine disposition

D. Oh, Joo-Youn Cho, K. Yu, 2004, Clinical pharmacology and therapeutics.

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers

D. Oh, Joo-Youn Cho, K. Yu, 2005, Clinical pharmacology and therapeutics.

Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states

D. Oh, Kwang-Hyeon Liu, Joo-Youn Cho, 2004, Clinical pharmacology and therapeutics.

Therapeutic evaluation of sustained-releasing praziquantel (SRP) for clonorchiasis: phase 1 and 2 clinical studies.

Sung-Tae Hong, J. Chun, I. Jang, 2006, The Korean journal of parasitology.

Comparative Pharmacokinetics/Pharmacodynamics of Clopidogrel Besylate and Clopidogrel Bisulfate in Healthy Korean Subjects

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2012, Clinical Drug Investigation.

Simultaneous LC–MS–MS Determination of HM30181A, [2-(2-{4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]amide, as a new P-Glycoprotein Inhibitor and Its Two Metabolites, M1 and M2, in Human Plasma: Application to a Pharmacokinetic Study

Y. Choi, Joo-Youn Cho, K. Yu, 2011 .

Prediction and visualization of CYP2D6 genotype-based phenotype using clustering algorithms

Eun-Young Kim, Sang-Goo Shin, Jae-Gook Shin, 2017, Translational and clinical pharmacology.

Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk.

N. Rothman, D. Kang, Sue-Kyung Park, 2002, Cancer letters.

Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover

Joo-Youn Cho, K. Yu, I. Jang, 2011, Clinical therapeutics.

Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study

Jun Soo Kwon, Euitae Kim, Young Youn Kim, 2006, Human psychopharmacology.

Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers.

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2009, British journal of clinical pharmacology.

Genetic Polymorphisms of SULT1A1 and SULT1E1 and the Risk and Survival of Breast Cancer

Wonshik Han, Ji-Yeob Choi, Sei-Hyun Ahn, 2005, Cancer Epidemiology Biomarkers & Prevention.

Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer

W. Han, D. Noh, R. Hayes, 2006, Breast Cancer Research and Treatment.

Effect of Erythrocyte Thiopurine Methyltransferase (TPMT) Activity on Azathioprine Immunosuppression Therapy in Renal Transplant Recipients

C. Ahn, J. Ha, Joo-Youn Cho, 2000 .

Angiotensin II type 1 receptor 1166A/C polymorphism in association with blood pressure response to exogenous angiotensin II

Hyeong-Seok Lim, Kyun-Seop Bae, Sang-Goo Shin, 2006, European Journal of Clinical Pharmacology.

Pharmacodynamics, Pharmacokinetics, and Tolerability of Intravenous or Subcutaneous GC1113, a Novel Erythropoiesis-Stimulating Agent

Jongtae Lee, Joo-Youn Cho, K. Yu, 2014, Clinical Drug Investigation.

Simple and sensitive determination of the new antitumor drug CKD-602 in human plasma by liquid chromatography.

Joo-Youn Cho, K. Yu, S. Yi, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The use of healthy volunteers instead of patients to inform drug dosing studies: a [11C]raclopride PET study

F. Turkheimer, S. Kapur, J. Kwon, 2011, Psychopharmacology.

Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover study.

K. Yu, I. Jang, K. Lim, 2012, Clinical therapeutics.

Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers

J. Kwon, H. Jo, Jong-Min Lee, 2008, Pharmacogenetics and genomics.

Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers.

Joo-Youn Cho, K. Yu, I. Jang, 2014, British journal of clinical pharmacology.

Pharmacokinetics and Tolerability of Naftopidil after a Single Oral Administration in Healthy Korean Volunteers

K. Yu, I. Jang, SeungHwan Lee, 2010 .

Assessment of the Drug–Drug Interactions Between Fimasartan and Hydrochlorothiazide in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2012, Journal of cardiovascular pharmacology.

Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2013, BioDrugs.

Utility of a One‐Point (3‐Hour Postdose) Plasma Metabolic Ratio as a Phenotyping Test Using Metoprolol in Two East Asian Populations

K. Chiba, T. Ishizaki, I. Jang, 1992, Therapeutic drug monitoring.

Influence of Simvastatin on Pharmacokinetics/Pharmacodynamics of Aspirin after Oral Co-administration in Healthy Volunteers

D. Yim, K. Yu, I. Jang, 2011 .

History of clinical pharmacology in Korea

Sang‐Goo Shin, 2014 .

Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6*10 genotype of Korean subjects

D. Flockhart, I. Jang, Jae-Gook Shin, 2000, Clinical pharmacology and therapeutics.

Comparative Pharmacokinetics of HD203, a Biosimilar of Etanercept, with Marketed Etanercept (Enbrel ®)

Joo-Youn Cho, K. Yu, I. Jang, 2012, BioDrugs.

Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: an open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteers.

K. Yu, I. Jang, Tae-Eun Kim, 2010, Clinical therapeutics.

Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies.

K. Yu, Jung-Ryul Kim, I. Jang, 2010, Clinical therapeutics.

Comparative pharmacokinetics and tolerability of branded etanercept (25 mg) and its biosimilar (25 mg): a randomized, open-label, single-dose, two-sequence, crossover study in healthy Korean male volunteers.

K. Yu, I. Jang, Tae-Eun Kim, 2011, Clinical therapeutics.

Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.

Joo-Youn Cho, K. Yu, I. Jang, 2010, Clinical therapeutics.

Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19.

D. Yim, Joo-Youn Cho, K. Yu, 2002, British journal of clinical pharmacology.

The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory

Jae Kyeong Jeong, F. Turkheimer, S. Kapur, 2012, Psychopharmacology.

Assessment of the pharmacokinetics of co-administered metformin and lobeglitazone, a thiazolidinedione antihyperglycemic agent, in healthy subjects

Joo-Youn Cho, K. Yu, I. Jang, 2012, Current medical research and opinion.

Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single- and multiple-dose, double-blind, randomized control study in healthy male Korean subjects.

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2011, Clinical therapeutics.

Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea.

K. Yu, I. Jang, Sang-Goo Shin, 2009, Clinical therapeutics.

Effect of UGT2B7 Genotype on Pharmacokinetics of Valproate in Human Healthy Subjects

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2004 .

Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers.

K. Yu, I. Jang, S. Yoon, 2009, Clinical therapeutics.

Pharmacokinetic Interaction of Fimasartan, a New Angiotensin II Receptor Antagonist, With Amlodipine in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2011, Journal of cardiovascular pharmacology.

Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin

Min Goo Lee, Joo-Youn Cho, K. Yu, 2013, Journal of clinical pharmacology.

The Effect of the Newly Developed Angiotensin Receptor II Antagonist Fimasartan on the Pharmacokinetics of Atorvastatin in Relation to OATP1B1 in Healthy Male Volunteers

Min Goo Lee, Joo-Youn Cho, K. Yu, 2011, Journal of cardiovascular pharmacology.

Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women.

Joong-Shin Park, K. Yu, I. Jang, 2013, Contraception.

Developing the Infrastructure for Clinical Trial in Korea

Hyun‐Sook Kang, S. Choung, Won-ock Kim, 2004 .

Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteers.

K. Yu, I. Jang, K. Lim, 2009, Clinical therapeutics.

Pharmacokinetic properties and effects of PT302 after repeated oral glucose loading tests in a dose-escalating study.

Sang-Heon Cho, K. Yu, I. Jang, 2014, Clinical therapeutics.

A Phase I study of cis‐malonato[(4R,5R)‐4,5‐bis(aminomethyl)‐1,3‐dioxolane] platinum(II) in patients with advanced malignancies

Y. Bang, D. Heo, Tae-You Kim, 2001, Cancer.

Pharmacokinetic characteristics of bepotastine besilate in healthy subjects

K. Yu, Hyeong-Seok Lim, I. Jang, 2007 .

Comparison of the bioavailability and tolerability of fixed-dose combination glimepiride/metformin 2/500-mg tablets versus separate tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Korean volunteers.

Joo-Youn Cho, K. Yu, Jae-Yong Chung, 2010, Clinical therapeutics.

An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects.

K. Yu, Jung-Ryul Kim, I. Jang, 2009, Clinical therapeutics.

Apple juice greatly reduces systemic exposure to atenolol.

K. Ohashi, Joo-Youn Cho, K. Yu, 2013, British journal of clinical pharmacology.

Calculating Occupancy when One does not have Baseline: A Comparison of Different Options

S. Kapur, J. Kwon, O. Howes, 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Multiple-dose pharmacokinetics of fesoterodine sustained-release in healthy Korean volunteers.

Joo-Youn Cho, K. Yu, I. Jang, 2012, International journal of clinical pharmacology and therapeutics.

Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations.

Eun-Young Kim, Sang-Goo Shin, Jae-Gook Shin, 2008, Clinica chimica acta; international journal of clinical chemistry.

Effect of cytochrome P450 2C19 genetic polymorphism and coadministration with ketoconazole on the platelet aggregation response to clopidogrel in Korean healthy subjects

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2009 .

No associations between 5-HTT, 5-HT2A gene polymorphisms and obsessive-compulsive disorder in a Korean population

J. Kwon, S. Yoo, Joo-Youn Cho, 2006 .

Immunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults.

W. Park, Joo-Youn Cho, K. Yu, 2011, Vaccine.

Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers

Joo-Youn Cho, K. Yu, I. Jang, 2012, Journal of clinical pharmacology.